NEURODON, LLC

NEURODON, LLC is a biotech company in CROWN POINT, United States, founded in 2018. It has raised $5.5M across 6 rounds, most recently a $1.2M Grant in September 2023.

Neurodon – Targeting cellular stress

Employees
1–10
Founded
2018
Total Funding
$5.5M
Last Round
$1.2M GrantSep 2023
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds and 3 investors for this company. The full record is or through the API.

About

Neurodon develops therapeutics targeting cellular stress and calcium imbalance associated with disease. Its research investigates activating the SERCA calcium pump to restore calcium balance and reverse cellular stress. Its therapeutics are in preclinical development for diabetes, Alzheimer’s, Parkinson’s, Duchenne muscular dystrophy, and other rare diseases.

Summary

It lists 1–10 employees. It has raised $5.5M in total across 6 rounds, most recently a $1.2M Grant round in Sep 2023. Investors include National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging and Elevate Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)Sep 2023
$1.2M

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NEURODON, LLC on Indexed.vc
<a href="https://indexed.vc/companies/neurodon-llc"><img src="https://indexed.vc/api/badge/company/neurodon-llc" alt="NEURODON, LLC on Indexed.vc" width="260" height="76" /></a>